- 专利标题: Clinical trial re-evaluation system
-
申请号: US16353952申请日: 2019-03-14
-
公开(公告)号: US10783990B2公开(公告)日: 2020-09-22
- 发明人: Kevin Lyman , Keith Lui , Anthony Upton , Li Yao , Ben Covington
- 申请人: Enlitic, Inc.
- 申请人地址: US CA San Francisco
- 专利权人: Enlitic, Inc.
- 当前专利权人: Enlitic, Inc.
- 当前专利权人地址: US CA San Francisco
- 代理机构: Garlick & Markison
- 代理商 Bruce E. Stuckman
- 主分类号: G06K9/00
- IPC分类号: G06K9/00 ; G16H10/60 ; H04L29/06 ; G16H30/40 ; G16H15/00 ; G06K9/62 ; G06T5/00 ; G06T5/50 ; G06T7/00 ; G06T11/00 ; G06N5/04 ; G16H30/20 ; G06N20/00 ; G06F9/54 ; G06T7/187 ; G06T7/11 ; G06F3/0482 ; G06T3/40 ; A61B5/00 ; G16H50/20 ; G06F21/62 ; G06Q20/14 ; G16H40/20 ; G06F3/0484 ; G06Q10/06 ; G16H10/20 ; G06T7/10 ; G06T11/20 ; G06F16/245 ; G06T7/44 ; G06N20/20 ; G06K9/20 ; H04L29/08 ; G16H50/70 ; G06T7/70 ; G16H50/30 ; A61B5/055 ; A61B6/03 ; A61B8/00 ; G06K9/66 ; A61B6/00 ; G06Q50/22 ; G06F40/295
摘要:
A clinical trial re-evaluation system is operable to perform at least one assessment function on a set of medical scans for each of a first subset of a set of patients of a failed clinical trial to generate automated assessment data for each of the first subset of the set of patients. The first subset of the set of patients corresponds to a subset of human assessment data determined to have failed to meet criteria of the clinical trial. Patient re-evaluation data is generated for each of the first subset of the set of patients by comparing the automated assessment data to the criteria. The patient re-evaluation data for a second subset of the first subset of the set of patients indicates the automated assessment data passes the criteria. Trial re-evaluation data is generated based on the patient re-evaluation data for transmission to a computing device for display.
公开/授权文献
- US20200160964A1 CLINICAL TRIAL RE-EVALUATION SYSTEM 公开/授权日:2020-05-21
信息查询